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Intracellular redox homeostasis is crucial
for maintaining healthy skeletal muscle.
Substantial redox imbalance due to excess
reactive oxygen species (ROS) production
is consequently associated with muscle
fatigue, functional decline, metabolic
dysfunction and even muscle wasting.
The nuclear factor erythroid-derived 2
(Nrf2)/Kelch ECH-associated protein 1
(Keap1) complex is a redox-sensitive trans-
criptional regulatory system pivotal for the
regulation of redox homeostasis, where
the cytoplasmic repressor protein, Keap1,
senses intracellular ROS and electrophiles,
and the transcription factor, Nrf2, promotes
antioxidant and other cytoprotective (e.g.
anti-inflammation, metabolism) gene
expression. In the resting state, Nrf2 is
sequestered in the cytoplasm by Keap1 and
targeted for proteasomal degradation and
thus antioxidant expression remains low.
However, in response to cellular stress,
intracellular ROS levels increase and several
Keap1 cystine residues become oxidised,
facilitating the liberation of Nrf2 from
Keap1. Nrf2 therein translocates to the
nucleus where it binds to antioxidant
response elements, in turn promoting the
transcription of antioxidant enzyme genes.
Targeted analytical research has shown
that exercise stress induces Nrf2-mediated
antioxidant expression in mouse skeletal
muscle (Li et al. 2015) and, conversely,
that Nrf2-deficient mice display higher
intramyocellular ROS levels and attenuated
antioxidant enzyme abundance (Miller
et al. 2012). Consequently, impaired
Nrf2/Keap1 function has been implicated
in skeletal myopathy and disease and the
Nrf2/Keap1 complex has been suggested
as a promising therapeutic target against
such pathologies. However, despite growing
evidence for the Nrf2/Keap1 complex
as a powerful intramuscular antioxidant
system, the precise biological implications
of Nrf2 in skeletal muscle tissue remain
poorly defined.
In a recent article published in The
Journal of Physiology (Gao et al. 2020),
the authors aimed to address this current
research aperture by applying untargeted
proteomic analysis to Nrf2-deficient
or Nrf2-overexpressed mouse skeletal
muscle tissue in order to identify a
broad spectrum of novel targets and
downstream pathways of Nrf2. For this
purpose, two skeletal muscle-specific
transgenic mouse models were produced:
(i) iMS-Nrf2flox/flox, a model for Nrf2
deficiency, and; (ii) iMS-Keap1flox/flox,
a model for Nrf2 overexpression. At
12 weeks of age, intraperitoneal injection
of tamoxifen (or vehicle control) was
administered for five consecutive days
to activate Cre-recombination and thus
induce selective Nrf2 (Nrf2-KO) or
Keap1 (Keap1-KO) gene inactivation. At
32 weeks of age, mice were assigned to
two cohorts for functional assessment
and proteomic/bioinformatic analysis of
skeletal muscle. Functional assessment
included maximal exercise capacity via
treadmill running, in situ muscle contra-
ctility under 2% isoflurane anaesthesia
via tetanic stimulation, targeted protein
content via immunoblotting, glutathione
content via glutathione assays and
mitochondrial function via high resolution
respirometry and citrate synthase activity.
Proteome-wide expression was quantified
using mass spectrometry, with the resultant
data being subjected to downstream
proteomic/bioinformatic analyses.
Gao et al. (2020) reported many inter-
esting and novel findings. First, Nrf2-KO
mice displayed significantly impaired
maximal running speed, distance, duration
and reduced muscle force-generating
capacity (compared with vehicle, i.e.
Nrf2-WT mice), whereas these performance
parameters were improved in Keap1-KO
mice, suggesting that Nrf2 has potent
effects on skeletal muscle function. This
is perhaps to be expected given the
mechanisms of action of the Nrf2/Keap1
complex: specifically, that reduced Nrf2
(i.e. Nrf2-KO) leads to reduced antioxidant
expression (either in the rested state
and/or in response to exercise stress)
and therein a redox imbalance, in turn
negatively affecting muscle function.
Second, differential protein-level analysis
revealed 114 differentially expressed
proteins in Nrf2-KO mouse muscle (11
upregulated, 103 downregulated) and
117 differentially expressed proteins in
Keap1-KO mouse muscle (108 upregulated,
nine downregulated), of which 10 proteins
were found to be commonly regulated.
Given this overall lack of commonality,
the authors suggest that regulated proteins
can be distinguished into two distinct
categories: (i) upregulated proteins in
Keap1-KO muscle are molecular targets
activated by a high level of Nrf2, and;
(ii) downregulated proteins in Nrf2-KO
muscle are Nrf2 targets, which rely on basal
Nrf2 activity. Downstream Gene Ontology
enrichment analysis and Ingenuity
Pathway Analysis (IPA) of differentially
expressed proteins expectedly revealed that
proteins upregulated by Keap1-KO were
involved in well-known Nrf2 functions
(e.g. detoxification, antioxidant defence).
However, Nrf2-KO regulated proteins
were found to be involved in (e.g.) purine
ribonucleoside triphosphate metabolism,
of which the implications are currently
unclear. A particularly striking finding
was that Nrf2-KO downregulated proteins
were associated with many aspects of
mitochondrial dysfunction, including
abnormal mitochondrial morphology
(COQ7), volume, length and coupling of
the mitochondria (AK1), transmembrane
potential of mitochondria (PHB and
YWHAE), permeability transition of
mitochondria (PPID) and mitochondrial
complex I deficiency (NDUFS6) –
implicating a role for, and candidate
mechanistic targets of, Nrf2-related
regulation of muscle mitochondrial health/
remodelling. Mitochondrial disturbance
was subsequently confirmed at the
functional level. Specifically, citrate
synthase activity and electron transport
chain (ETC) complex protein expression
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were reduced in Nrf2-KO mouse muscle,
indicative of reduced muscle mitochondrial
content. Further, coupled mitochondrial
respiration of the soleus muscle was lower
in Nrf2-KO mice (compared with Nrf2-WT,
Keap1-KO and Keap1-WT mice), with
no changes observed in Keap1-KO mice
(vs. Keap1-WT mice). Thus, it would
be logical to postulate that reductions
in mitochondrial respiration may be
a cause/consequence of reduced ETC
protein content and/or a more globally
occurring dysregulation of mitochondrial
function-related proteins, as indicated by
untargeted proteomics.
When interpreting the results pre-
sented by Gao et al. (2020), a number
of important caveats/limitations are
worthy of mention. First, as the authors
themselves highlight, the sample size
available for mass spectrometry-based
analysis was small (n = 3/group),
perhaps increasing the likelihood of
false-negative and/or false-positive results.
Larger group sizes would have also better
facilitated the incorporation of more
holistic bioinformatic tools into the
analysis pipeline. One example is weighted
co-expression network analysis (Pei et al.
2017), wherein molecular complexity is
accounted for by modelling interactions
among all molecules contained within
a large-scale dataset as a function of
expression similarity. Such a data-driven
form of network modelling could have
further extended novel mechanistic insight
into the biological relevance of Nrf2 in
skeletal muscle beyond knowledge-based
pathway modelling of individually
regulated proteins (e.g. IPA); namely, by
providing a framework to derive entirely
new pathways of interacting proteins
(dys)regulated by Nrf2-KO/Keap1-KO, the
key ‘hub’ components of such pathways
and, importantly, novel pathways that
might be directly associated with the
observed functional consequences of
Nrf2-KO/Keap1-KO (Uddin & Singh,
2017). It is also worthwhile mentioning
that Nrf2-KO/Keap1-KO protein changes
have been generalized to be changes in
skeletal muscle per se. Yet, the presented
volcano plots (Figure 3A) suggest that
Nrf2-KO protein changes are in fact driven
by changes in the extensor digitorum
longus (EDL), whereas Keap1-KO protein
changes are instead driven by changes in the
soleus. It is well established that these two
particular muscles are markedly different
from one another in terms of fibre-type
distribution (i.e. EDL is predominantly
composed of fast-twitch fibres whereas
the soleus is predominantly composed of
slow-twitch fibres) and, as a consequence,
also differ in their mitochondrial capacity
(i.e. lower mitochondrial capacity in EDL
vs. soleus). Such a caveat is important
to consider in relation to the authors’
interpretation of Nrf2 function in muscle,
since it is plausible that the overall functions
of/specific mitochondrial regulation by
Nrf2 in skeletal muscle may partly depend
on muscle/fibre type, as the proteomic
data suggest. Further demonstrating this
point, the authors found Troponin T
protein, which is specific to fast-twitch
fibres, to be downregulated in Nrf2-KO
muscle, which we expect is probably
driven by Nrf2-KO-induced changes
in the EDL (as opposed to skeletal
muscle per se). Therefore, the biological
role/mechanisms of Nrf2 may be distinct
in different muscles owing to differences
in fibre-type distribution (and thus the
underlying metabolic and molecular
characteristics), a hypothesis worthy of
further investigation. Finally, whilst a
thorough and well-conducted investigation
has been conducted by Gao et al. (2020),
it must be remembered that these findings
are based on data obtained from transgenic
mice, thus precluding direct translation to
humans.
As with any novel experiment, numerous
follow-up questions and future research
avenues directly arise from the findings
observed by Gao et al. (2020). For
example, where might the onset of muscle
mitochondrial dysfunction occur in the
context of Nrf2-KO? The adoption of a
systems biology approach (i.e. integrated
genomics, transcriptomics and proteomics)
into a data-driven network framework,
a feat rightly becoming more popular
within physiology, should help identify
such (e.g.) transcriptional reprogramming
under said conditions and thus help
answer such fundamental biological
questions.
In summary, Gao et al. (2020) advance our
current understanding on the biological
relevance of Nrf2 in skeletal muscle, with
a key finding being that Nrf2 deficiency
leads to muscle mitochondrial dysfunction.
Further, by delving into the analytical world
of proteomics and bioinformatic analysis,
Gao et al. highlight mitochondrial targets
of Nrf2, which may in turn represent
promising candidates for therapeutic
intervention.
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